Nuveen
PAHC icon

Nuveen’s Phibro Animal Health PAHC Stock Holding History

Nuveen’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.86M Sell
314,079
-141,812
-31% -$5.98M ﹤0.01% 1697
2026
Q1 		$25.2M Buy
455,891
+11,623
+3% +$553K 0.01% 1001
2025
Q4 		$16.6M Sell
444,268
-34,950
-7% -$1.42M ﹤0.01% 1254
2025
Q3 		$19.4M Buy
479,218
+19,505
+4% +$644K 0.01% 1173
2025
Q2 		$11.7M Sell
459,713
-23,060
-5% -$503K ﹤0.01% 1414
2025
Q1 		$10.3M Sell
482,773
-105,228
-18% -$2.35M ﹤0.01% 1537
2024
Q4 		$12.3M Buy
588,001
+103,618
+21% +$2.4M ﹤0.01% 1487
2024
Q3 		$10.9M Buy
484,383
+137,773
+40% +$2.66M ﹤0.01% 1546
2024
Q2 		$5.81M Sell
346,610
-100,127
-22% -$1.61M ﹤0.01% 1871
2024
Q1 		$5.78M Buy
446,737
+176,168
+65% +$2.11M ﹤0.01% 1910
2023
Q4 		$3.13M Sell
270,569
-24,589
-8% -$278K ﹤0.01% 2200
2023
Q3 		$3.77M Sell
295,158
-15,404
-5% -$218K ﹤0.01% 2007
2023
Q2 		$4.25M Sell
310,562
-105,046
-25% -$1.51M ﹤0.01% 2005
2023
Q1 		$6.37M Buy
415,608
+68,881
+20% +$1.05M ﹤0.01% 1752
2022
Q4 		$4.65M Buy
346,727
+13,262
+4% +$178K ﹤0.01% 1954
2022
Q3 		$4.43M Sell
333,465
-5,649
-2% -$97.5K ﹤0.01% 1975
2022
Q2 		$6.49M Buy
339,114
+10,964
+3% +$208K ﹤0.01% 1780
2022
Q1 		$6.62M Sell
328,150
-3,844
-1% -$77.6K ﹤0.01% 1907
2021
Q4 		$6.24M Sell
331,994
-6,811
-2% -$145K ﹤0.01% 1987
2021
Q3 		$7.33M Buy
338,805
+6,627
+2% +$160K ﹤0.01% 2000
2021
Q2 		$9.59M Sell
332,178
-30,753
-8% -$832K ﹤0.01% 1896
2021
Q1 		$8.86M Buy
362,931
+14,219
+4% +$321K ﹤0.01% 1868
2020
Q4 		$6.77M Buy
348,712
+77,801
+29% +$1.43M ﹤0.01% 1917
2020
Q3 		$4.71M Sell
270,911
-157,390
-37% -$3.36M ﹤0.01% 1949
2020
Q2 		$11.3M Sell
428,301
-88,049
-17% -$2.19M ﹤0.01% 1412
2020
Q1 		$12.5M Buy
516,350
+70,653
+16% +$1.73M 0.01% 1163
2019
Q4 		$11.1M Sell
445,697
-36,322
-8% -$843K ﹤0.01% 1533
2019
Q3 		$10.3M Sell
482,019
-78,156
-14% -$2.14M ﹤0.01% 1552
2019
Q2 		$17.8M Buy
+560,175
New +$17.6M 0.01% 1224

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Nuveen's PAHC Position: Q2 2026 in Review

Nuveen reduced its Phibro Animal Health (PAHC) stake by 31% in Q2 2026, selling an estimated $5.98M and leaving 314,079 shares worth $9.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1697.

Nuveen first reported a position in PAHC in Q2 2019 and has held it in 29 quarters since. The position peaked at $25.2M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Nuveen held 314,079 shares of Phibro Animal Health worth $9.86M as of Q2 2026.
  • Nuveen sold 141,812 Phibro Animal Health shares in Q2 2026, an estimated $5.98M.
  • Phibro Animal Health made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1697 holding.
  • Nuveen first reported a position in Phibro Animal Health in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Phibro Animal Health position peaked at $25.2M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.